BioSpace News Archive

Drug Development

Resverlogix Announces Fifth Positive Recommendation From Data Safety Monitoring Board for Phase III Study of Apabetalone

A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification.

November 1, 2017
·
3 min read
Business

Pain Therapeutics Reports Third Quarter 2017 Financial Results

The Company still expects net cash usage in the calendar year 2017 may be approximately $10 million.

November 1, 2017
·
8 min read
Business

Chimerix to Announce Third Quarter 2017 Financial Results on November 8, 2017

An archived webcast will be available on the Chimerix website approximately two hours after the event.

November 1, 2017
·
1 min read
Drug Development

AbbVie Announces Positive Phase III Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis With Associated Pain

In the extension studies, elagolix demonstrated sustained reduction in average monthly menstrual pelvic pain and non-menstrual pelvic pain in women through the 12-month treatment period.

November 1, 2017
·
10 min read
Business

Sarah Steele Chang Joins Bioz as VP of Sales

Chang will be responsible for the management of all sales efforts and the growth and development of Bioz’s sales teams.

November 1, 2017
·
2 min read
Genetown

Takeda to Showcase Data That May Reshape the Future of Blood Cancer Treatments During 59th ASH Annual Meeting

Eleven Takeda-sponsored abstracts were accepted for presentation during ASH 2017.

November 1, 2017
·
41 min read
Business

iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8

The company will release financial results for the three and nine months ended September 30, 2017 after the close of the market.

November 1, 2017
·
3 min read
Biotech Bay

Genentech to Present New Data Across a Range of Blood Diseases at the ASH 2017 Annual Meeting

Ten Genentech medicines will be featured in over 75 abstracts, including 26 oral presentations, across eight blood diseases.

November 1, 2017
·
28 min read
Business

Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 15, 2017

The company will report its financial results for the three and nine months ended September 30, 2017.

November 1, 2017
·
1 min read
Business

EDAP TMS to Announce Third Quarter 2017 Financial Results on Wednesday, November 15, 2017

Management will host a conference call to review the results.

November 1, 2017
·
3 min read